Natalia García-San-Martín, Richard A I Bethlehem, Agoston Mihalik, Jakob Seidlitz, Isaac Sebenius, Claudio Alemán-Morillo, Lena Dorfschmidt, Golia Shafiei, Víctor Ortiz-García de la Foz, Kate Merritt, Anthony David, Sarah E Morgan, Miguel Ruiz-Veguilla, Rosa Ayesa-Arriola, Javier Vázquez-Bourgon, Aaron Alexander-Bloch, Bratislav Misic, Edward T Bullmore, John Suckling, Benedicto Crespo-Facorro, Rafael Romero-García
The psychosis spectrum encompasses a heterogeneous range of clinical conditions associated with abnormal brain development. Detecting patterns of atypical neuroanatomical maturation across psychiatric disorders requires an interpretable metric standardized by age-, sex- and site-effect. The molecular and micro-architectural attributes that account for these deviations in brain structure from typical neurodevelopment are still unknown. Here, we aggregate structural magnetic resonance imaging data from 38,696 healthy controls (HC) and 1256 psychosis-related conditions, including first-degree relatives of schizophrenia (SCZ) and schizoaffective disorder (SAD) patients (n = 160), individuals who had psychotic experiences (n = 157), patients who experienced a first episode of psychosis (FEP, n = 352), and individuals with chronic SCZ or SAD (n = 587)...
September 12, 2024: Molecular Psychiatry